NewEdge Advisors’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$11.7M Buy
109,313
+13,527
+14% +$1.45M 0.06% 331
2025
Q1
$9.66M Buy
95,786
+6,891
+8% +$695K 0.06% 334
2024
Q4
$7.94M Buy
88,895
+5,416
+6% +$484K 0.05% 373
2024
Q3
$7M Buy
83,479
+2,172
+3% +$182K 0.05% 371
2024
Q2
$6.26M Buy
81,307
+20,644
+34% +$1.59M 0.05% 383
2024
Q1
$4.15M Buy
60,663
+19,573
+48% +$1.34M 0.04% 443
2023
Q4
$2.42M Sell
41,090
-10,057
-20% -$593K 0.02% 600
2023
Q3
$2.7M Buy
51,147
+18,629
+57% +$984K 0.03% 497
2023
Q2
$1.76M Buy
32,518
+2,041
+7% +$110K 0.02% 633
2023
Q1
$1.54M Buy
30,477
+4,837
+19% +$244K 0.02% 618
2022
Q4
$785K Buy
25,640
+3,478
+16% +$107K 0.02% 596
2022
Q3
$858K Sell
22,162
-4,010
-15% -$155K 0.01% 703
2022
Q2
$976K Buy
26,172
+13,153
+101% +$490K 0.02% 673
2022
Q1
$577K Sell
13,019
-3,763
-22% -$167K 0.01% 810
2021
Q4
$713K Buy
16,782
+1,190
+8% +$50.6K 0.01% 900
2021
Q3
$677K Buy
15,592
+8,481
+119% +$368K 0.02% 667
2021
Q2
$304K Buy
+7,111
New +$304K 0.01% 897
2020
Q4
Sell
-10,974
Closed -$419K 990
2020
Q3
$419K Buy
10,974
+548
+5% +$20.9K 0.01% 625
2020
Q2
$366K Buy
10,426
+1,672
+19% +$58.7K 0.01% 626
2020
Q1
$286K Sell
8,754
-1,858
-18% -$60.7K 0.01% 613
2019
Q4
$479K Sell
10,612
-846
-7% -$38.2K 0.02% 542
2019
Q3
$464K Buy
11,458
+2,101
+22% +$85.1K 0.02% 515
2019
Q2
$402K Buy
9,357
+1,364
+17% +$58.6K 0.02% 452
2019
Q1
$307K Sell
7,993
-98
-1% -$3.76K 0.02% 514
2018
Q4
$286 Buy
8,091
+172
+2% +$6 0.02% 496
2018
Q3
$305K Buy
+7,919
New +$305K 0.02% 487
2017
Q3
Sell
-2,413
Closed -$66.5K 455
2017
Q2
$66.5K Buy
+2,413
New +$66.5K 0.01% 485
2017
Q1
Sell
-25,954
Closed -$603K 276
2016
Q4
$603K Buy
+25,954
New +$603K 0.17% 132